← Back to Analyst Consensus 
EHC Buy
Encompass Health Corp
Current Price —
Implied Upside —
Analysts 18
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Oct 28, 2026 (2 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 10, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Aug 7, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Aug 7, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Aug 6, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 28, 2026 | TD Cowen | initiate | — → Buy | — | 54% |
| May 5, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Feb 6, 2026 | Barclays | maintain | Overweight → Overweight | $153 | 53% |
| Oct 30, 2025 | Barclays | maintain | Overweight → Overweight | $150 | 53% |
| Oct 2, 2025 | UBS | maintain | Buy → Buy | $150 | 54% |
| Sep 16, 2025 | Keybanc | maintain | Overweight → Overweight | $140 | 52% |
| Sep 10, 2025 | B of A Securities | maintain | Buy → Buy | $160 | 53% |
| Aug 14, 2025 | Truist Securities | maintain | Buy → Buy | $140 | 54% |
| Aug 6, 2025 | UBS | maintain | Buy → Buy | $140 | 54% |
| Jun 5, 2025 | Stephens & Co. | reiterate | Overweight → Overweight | $135 | 54% |
| May 27, 2025 | Keybanc | maintain | Overweight → Overweight | $135 | 52% |
| Apr 28, 2025 | UBS | maintain | Buy → Buy | $130 | 54% |
| Apr 28, 2025 | RBC Capital | maintain | Outperform → Outperform | $125 | 55% |
| Apr 28, 2025 | Truist Securities | reiterate | Buy → Buy | $135 | 54% |
| Apr 25, 2025 | Keybanc | maintain | Overweight → Overweight | $122 | 52% |
| Apr 25, 2025 | Barclays | maintain | Overweight → Overweight | $129 | 53% |
| Feb 11, 2025 | RBC Capital | reiterate | Outperform → Outperform | $110 | 55% |
| Feb 10, 2025 | Keybanc | maintain | Overweight → Overweight | $120 | 52% |
| Feb 7, 2025 | Barclays | maintain | Overweight → Overweight | $118 | 53% |
| Oct 30, 2024 | RBC Capital | maintain | Outperform → Outperform | $110 | 55% |
| Oct 30, 2024 | Truist Securities | reiterate | Buy → Buy | $116 | 54% |
| Oct 29, 2024 | Barclays | maintain | Overweight → Overweight | $116 | 53% |
| Oct 29, 2024 | Keybanc | maintain | Overweight → Overweight | $117 | 52% |
| Oct 14, 2024 | Truist Securities | maintain | Buy → Buy | $108 | 54% |
| Oct 11, 2024 | Keybanc | initiate | — → Overweight | $115 | 52% |
| Sep 26, 2024 | RBC Capital | maintain | Outperform → Outperform | $105 | 55% |
| Sep 25, 2024 | UBS | maintain | Buy → Buy | $110 | 54% |
| Aug 15, 2024 | Truist Securities | maintain | Buy → Buy | $104 | 54% |
| Aug 8, 2024 | UBS | maintain | Buy → Buy | $100 | 54% |
| Aug 6, 2024 | Stephens & Co. | reiterate | Overweight → Overweight | $105 | 54% |
| Aug 6, 2024 | Barclays | maintain | Overweight → Overweight | $109 | 53% |
| Jul 15, 2024 | Truist Securities | maintain | Buy → Buy | $100 | 54% |
| Jul 10, 2024 | Barclays | maintain | Overweight → Overweight | $113 | 53% |
| Jul 10, 2024 | Leerink Partners | initiate | — → Outperform | $100 | 51% |
| Jun 5, 2024 | Stephens & Co. | reiterate | Overweight → Overweight | $94 | 54% |
| May 22, 2024 | RBC Capital | maintain | Outperform → Outperform | $95 | 55% |
| Apr 26, 2024 | Raymond James | reiterate | Strong Buy → Strong Buy | $95 | 54% |
| Apr 25, 2024 | Barclays | maintain | Overweight → Overweight | $108 | 53% |
| Apr 25, 2024 | Mizuho | maintain | Buy → Buy | $95 | 52% |
| Mar 28, 2024 | Barclays | maintain | Overweight → Overweight | $101 | 53% |
| Mar 6, 2024 | Barclays | initiate | — → Overweight | $95 | 53% |
| Feb 9, 2024 | Truist Securities | maintain | Buy → Buy | $86 | 54% |
| Feb 9, 2024 | RBC Capital | reiterate | Outperform → Outperform | $83 | 55% |
| Feb 9, 2024 | Mizuho | maintain | Buy → Buy | $82 | 52% |
| Jan 16, 2024 | Stephens & Co. | reiterate | Overweight → Overweight | $85 | 54% |
| Sep 28, 2023 | RBC Capital | reiterate | Outperform → Outperform | $83 | 55% |
Price Target Trend
Jun 28, 2026 Latest: $148.17 Oct 24, 2026
EPS Estimates
+1q $1.61
Lo: $1.45 Hi: $1.67
12 analysts 0y $6.11
Lo: $5.84 Hi: $6.19
13 analysts 0q $1.36
Lo: $1.25 Hi: $1.41
12 analysts ▲8
+1y $6.68
Lo: $6.15 Hi: $6.88
13 analysts ▲10
Cross-Platform Signals
No cross-platform signals in the last 90 days